Europe’s chemicals agency has improved its policy on the publication of information it receives from businesses that use ‘substances of very high concern’ (SVHC).
Human health and the environment are being put at risk because of excessive delays in chemical regulatory decisions by the European Commission, new research reveals.
Environmental lawyers from ClientEarth are calling on the European Chemicals Agency (ECHA) to redefine its role to better serve the public interest and not just the chemicals industry.
Analysis by ChemSec and ClientEarth shows the chemicals approval process gives undue influence to companies producing dangerous chemicals and stifles information on safer alternatives, limiting the market for companies that produce them.
A review of EU chemicals legislation, known as the REACH REFIT has been published by the European Commission. ClientEarth lawyers have read the communication and set out their preliminary thoughts.
The ECJ has confirmed that substances that are imported into the EU with the purpose of being subsequently exported, and which are not placed on the EU market, do not need to be registered under REACH.
Scientific experts from all over the EU have unanimously agreed that widely used chemical Bisphenol A (BPA) is an endocrine disruptor.
The Commission has ignored ClientEarth’s call to stop plastics recyclers using a hormone-harming chemical which causes infertility and developmental problems in children.
The European Commission is facing a new legal challenge after it approved the use of a dangerous neurotoxic chemical known to cause cancer, brain and nerve damage.
EU judges have sided with the chemicals industry, when they ruled that regulator ECHA does not need to release more data on the toxics being pumped into the environment.